InvestorsHub Logo

xstream

03/27/22 11:03 AM

#50353 RE: Mlady #50352

LOL if it wasn’t so serious. Good luck with your thinking.

tractor4sale

03/27/22 11:20 AM

#50357 RE: Mlady #50352

Let’s read the press release again!

“This pivotal trial has significant implications not only to COVID-19 patients with severe lung compromise but also the significant population of patients suffering from acute respiratory distress syndrome (ARDS),” said Dr. Thomas Ichim, Director of the Company. “If the trial is successful, we anticipate FDA registration of JadiCell as the first cell based therapeutic to address ARDS which represents a multibillion-dollar market”…

The “industry sponsored” ARDS clinical trials means nobody will be missing the boat…